Jesper Hallas
Syddansk Universitet
H-index: 78
Europe-Denmark
Top articles of Jesper Hallas
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns | Pharmacoepidemiology and Drug Safety | Thomas Delvin Anette Bygum Lars Christian Lund Jacob Harbo Andersen Jesper Hallas | 2024/1 |
Critical evaluation of articles on case-control studies. | Lars Christian Lund Anton Pottegård Henrik Toft Sørensen Jesper Hallas | 2024/2/12 | |
A case for screening real‐world data for collateral drug benefits: Glucagon‐like peptide 1 receptor agonists and bile acid diarrhea | Pharmacoepidemiology and Drug Safety | Martin Torp Rahbek Lars Christian Lund Jesper Hallas | 2024/1 |
Kritisk læsning af artikler om case-kontrol-studier | Lars Christian Lund A Pottegård Henrik Toft Sørensen Jesper Hallas | 2024/2/12 | |
Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program | Stefan de Vogel John D Seeger Alejandro Arana Andrea V Margulis Lisa J McQuay | 2024/5 | |
Use of molnupiravir: a Danish nationwide drug utilization study | Pharmacoepidemiology and Drug Safety | Louise Ladebo Lotte Rasmussen Peter Bjødstrup Jensen Mette Lindahl Anne Øvrehus | 2024/1 |
Risk of Stroke and Myocardial Infarction Among Initiators of Triptans | JAMA neurology | Christian Lund Petersen Anders Hougaard David Gaist Jesper Hallas | 2024/2/5 |
Is the sequence ratio an unbiased estimate of the incidence rate ratio? A simulation study | Pharmacoepidemiology and Drug Safety | Thomas Delvin Sofie Egsgaard Jesper Hallas Helene Kildegaard Lars Christian Lund | 2024/3 |
Impact of immunosuppressive therapy on SARS-CoV-2 mRNA vaccine effectiveness in patients with immune-mediated inflammatory diseases: a Danish nationwide cohort study | BMJ open | Rahma Elmahdi Daniel Ward Martin T Ernst Gry Poulsen Jesper Hallas | 2024/2/1 |
Critical evaluation of cohort study results. | Lars Christian Lund Anton Pottegård Henrik Toft Sørensen Jesper Hallas | 2024/2/26 | |
Identifying high‐risk medications and error types in Danish patient safety database using disproportionality analysis | Pharmacoepidemiology and Drug Safety | Olga Tchijevitch Søren F Birkeland Søren B Bogh Jesper Hallas | 2024/2 |
Kritisk læsning af artikler om kohortestudier | Ugeskrift for Laeger | Lars Christian Lund Anton Pottegård Henrik Toft Sørensen Jesper Hallas | 2024/2/26 |
Postmenopausal hormone therapy and mortality before and after the Women’s Health Initiative study | Scientific Reports | Laura Løkkegaard Johansen Mikael Thinggaard Jesper Hallas Merete Osler Kaare Christensen | 2023/1/11 |
The risk of fragility fractures following initiation of gabapentin and pregabalin—A Danish, nationwide, high‐dimensional propensity score‐matched cohort study | Basic & Clinical Pharmacology & Toxicology | Emilie Berg Jørgensen Lærke Karner Overgaard Lars Folkestad Per Damkier Jesper Hallas | 2023/5 |
Continuous intravenous glucagon in children with congenital hyperinsulinism: A retrospective single center evaluation of effects and adverse effects | IMPE Abstracts | Ahmad Jonas Husnan Anette Bygum Jesper Hallas Ilieana Vasilescu Nielsen Peter Stenbakken | 2023/2/14 |
Sudden Sensorineural Hearing Loss Following Immunization With BNT162b2 or mRNA‐1273: A Danish Population‐Based Cohort Study | Otolaryngology–Head and Neck Surgery | Per Damkier Brian Cleary Jesper Hallas Jesper H Schmidt Louise Ladebo | 2023/12 |
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses | bmj | Niklas Worm Andersson Emilia Myrup Thiesson Ulrike Baum Nicklas Pihlström Jostein Starrfelt | 2023/7/24 |
Protocol: Effect of single versus multiple prophylactic antibiotic doses on prosthetic joint infections following primary total hip arthroplasty in patients with osteoarthritis … | BMJ Open | Armita Armina Abedi Claus Varnum Alma Becic Pedersen Kirill Gromov Jesper Hallas | 2023 |
Methodology of the brodalumab assessment of hazards: a multicentre observational safety (BRAHMS) study | BMJ open | Mette Reilev Peter Bjødstrup Jensen Lise Skov Ranch Alexander Egeberg Kari Furu | 2023/2/1 |
Major cardiovascular events after spontaneous intracerebral hemorrhage by hematoma location | JAMA network open | Nils Jensen Boe Stine Munk Hald Mie Micheelsen Jensen Line Marie Buch Kristensen Jonas Asgaard Bojsen | 2023/4/3 |
Co-Authors
